In summary, this study demonstrated for the first time that EcN protects the intestinal barrier function in sepsis both in vivo and in vitro and suggested that the inhibition of the NF-κB-mediated MLCK-P-MLC signaling pathway might be one of the potential mechanisms of the protective effect of EcN. The gene discussed is NFKB1; the disease is Sepsis.